Last Updated: September 24, 2026

CORDARONE Drug Patent Profile

Name: CORDARONE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Cordarone, and when can generic versions of Cordarone launch?

Cordarone is a drug marketed by Wyeth Pharms Inc and Wyeth Pharms and is included in two NDAs.

The generic ingredient in CORDARONE is amiodarone hydrochloride. There is one drug master file entry for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cordarone

A generic version of CORDARONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30^th, 1998.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CORDARONE?
What are the global sales for CORDARONE?
What is Average Wholesale Price for CORDARONE?

Summary for CORDARONE

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	67
Clinical Trials:	27
Patent Applications:	6,048
DailyMed Link:	CORDARONE at DailyMed

Drug patent expirations by year for CORDARONE

Recent Clinical Trials for CORDARONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
OHSU Knight Cancer Institute	Phase 2
University of Calgary	Phase 4
University Hospital, Caen	Phase 4

See all CORDARONE clinical trials

US Patents and Regulatory Information for CORDARONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	CORDARONE	amiodarone hydrochloride	INJECTABLE;INJECTION	020377-001	Aug 3, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Pharms	CORDARONE	amiodarone hydrochloride	TABLET;ORAL	018972-001	Dec 24, 1985		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.